Non-Valvular Atrial Fibrillation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients who have been given the definitive diagnosis of NVAF and who have the ability to attend the hospital at specified visits. If a new diagnosis of NVAF is to be given to a patient, ECG, Holter ECG, portable ECG, echocardiography, etc. should be performed to make a definitive diagnosis. (2)Patients aged 75 years or more at the time of informed consent (male or female patients) (3)Patients who have given informed consent in writing
Exclusion criteria
Exclusion criteria: (1)Patients who are currently participating/who are planning to participate in an interventional study (2)Patients who have been given the definitive diagnosis of mitral stenosis (3)Patients who have an artificial heart valve (mechanical valve or tissue valve prostheses) in their body (4)Patients who have experienced any cardiovascular event (stroke, myocardial infarction, cardiac intervention for cardiac events other than myocardial infarction, or heart failure requiring hospitalization) or any bleeding leading to hospitalization within one month before enrollment (5)Patients who have been diagnosed as having a life expectancy of less than one year for some kind of disease (6)Patients for whom participation in this study is inappropriate for other reason than those mentioned in the exclusion criteria above
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of stroke/systemic embolism during the observation period | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of the following events during the observation period: (1)Hemorrhagic adverse events (major bleeding) (2)Stroke (3)Systemic embolism (4)Ischemic stroke (5)Hemorrhagic stroke (6)Intracranial hemorrhage (7)Cardiovascular events (stroke, myocardial infarction, cardiac intervention for cardiac events other than myocardial infarction, or heart failure requiring hospitalization) (8)Death from cardiovascular disease (death for which possibility of causal relationship with any cardiovascular factor cannot be excluded) (9)All-cause mortality | — |
Countries
Japan
Contacts
IQVIA Services Japan G.K. Real-World Evidence Services